Research report covers the Ventilator-Associated Pneumonia Market Forecasts and Growth, 2020-2027

 Market Scenario 

The global ventilator-associated pneumonia market is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 968.92 million in 2018 and is projected to register a 9.45% CAGR over the forecast period. Ventilator-associated pneumonia is a type of lung infection that affects patients who are on ventilators. It is caused because of lung diseases, neurological diseases, and trauma. Factors such as the growing prevalence of ventilator-associated pneumonia and increasing incidences of traumatic brain injury are expected to drive the market growth. According to a report published by the National Center for Biotechnology Information (NCBI) in November 2017, the incidence rate for ventilator-associated pneumonia ranges from 5% to 67%, depending upon the case. Moreover, the increasing research and development expenditure for the development of effective treatment for the disease is further boosting the market growth. However, factors such as expensive diagnostic tests, high ventilator charges, and inappropriate reimbursement scenarios are expected to hamper the market growth. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1377  

Segmentation The global ventilator-associated pneumonia market has been segmented into diagnosis, end users, and region. Based on diagnosis, the global ventilator-associated pneumonia market has been segmented into clinical, radiological, microbiological, and others. The microbiological diagnosis segment is further classified into blood & pleural fluid cultures, nonquantitative or semi-quantitative airway sampling, and quantitative cultures of airway specimens. The global ventilator-associated pneumonia market, by end user, has been categorized into hospitals & clinics, research & academic institutes, ambulatory care centers, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The ventilator-associated pneumonia market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European ventilator-associated pneumonia market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified into France, Germany, Spain, the UK, Italy, and the rest of Western Europe.  The ventilator-associated pneumonia market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ventilator-associated pneumonia market in Middle East & Africa is segmented into the Middle East and Africa.     

Key Players 

Adenium Biotech ApS (Denmark), Merck & Co., Inc. (US), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Ireland), Thermo Fisher Scientific (US), Bayer AG (Germany), Wockhardt (India), Shionogi Inc. (Japan), Cardeas Pharma (US) are some of the key players operating in the global ventilator-associated pneumonia market.   

Regional Market Summary

Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to dominate the global ventilator-associated pneumonia market owing to the prevalence of ventilator-associated pneumonia and growing initiatives by the government and non-government organizations to control the growth of the disease. Europe is expected to hold the second-largest share of the ventilator-associated pneumonia market. The presence of a large patient population suffering from lung diseases and well-developed healthcare industry drives the market growth in this region. Asia-Pacific is expected to be the fastest-growing regional market owing to the growing initiatives taken by the government and non-government organizations to create awareness regarding the prevalence rate of various infectious diseases and increasing incidences of ventilator-associated pneumonia. According to a report published by the Indian Chest Society in August 2016, the incidence rate of ventilator-associated pneumonia is approximately 13.6 per 1000 mechanical ventilation days in India. The ventilator-associated pneumonia market in the Middle East & Africa holds the least share of the market. The Middle Eastern market is expected to hold a significant market share of this region owing to growing government initiatives for developing the healthcare industry in this region. The African market is expected to grow due to high prevalence of infectious diseases.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377 

Surgical Chips Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Market Scenario:

A surgical chip is a recognizing coordinated circuit gadget / RFID transponder encased in silicate glass and embedded in the body of a person. A sub dermal implant ordinarily contains an exceptional ID number that can be connected to data contained in an outside database, for example, individual recognizable proof, medicinal history, meds, allergies, and contact information. The global Surgical Chips Market is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1310 

Key Players for Surgical Chips Market:

Some of the key players in this market are: Abbott Laboratories (US) Agilent Technologies, Inc. (US) Perkinelmer, Inc. (US) Fluidigm Corporation (US) Illumina, Inc. (US) GE Healthcare (UK)  Bio-Rad Laboratories Inc. (US)  Cepheid (US),  Thermo Fisher Scientific, Inc. (US)  Roche Diagnostics (Switzerland)

Segments:

Global Surgical Chips market has been segmented on the basis of types which comprises of DNA Chips, brain chips, lab chips, protein chips, tissue chip and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of application which consists of Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, Clinical Diagnostics and others

Regional Analysis of Surgical Chips Market:

Globally North America is the largest market for Surgical Chips. The North American market for Surgical Chips is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is due to increasing healthcare R&D expenditure and improvement of healthcare technology. Europe is the second-largest market for Surgical Chips which is expected to grow at a CAGR of XX%. Whereas Asia pacific is expected to be a growing market for Surgical Chips market

The report for Global Surgical Chips

 Global Surgical Chips market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-chips-market-1310 

Throat Lozenges Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 

Market Overview

According to MRFR,   the global throat lozenges market is expected to witness a moderate CAGR of 4.20% and generate a market value of USD 6.58 Billion by the end of 2023.

COVID-19 Analysis

A positive effect of the COVID-19 pandemic is expected on the Global Throat Lozenges Market. The typical signs of COVID-19 are a sore throat and coughing. Therefore, people under home confinement have been using at-home remedies for COVID-19 such as throat lozenges for chronic cough and over-the-counter pain relief for body aches. Therefore, in the next 2 to 3 years, the growing demand for throat lozenges for the treatment of initial COVID-19 symptoms of coughing and throat pain is expected to fuel the growth of the market for throat lozenges. The growing demand for throat lozenges has also led to the production of throat lozenges by companies from different industries. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1212

Growing Prevalance of Sore Throat Causing Disorders to Drive Market Growth

Throat lozenges are sold in bulk and are low-cost for the treatment of sore throat caused by respiratory illnesses or common cold, similar to most medical options. Similarly, the growth of the demand for throat lozenges is also driven by a growing number of HIV patients around the world, since HIV patients typically suffer from throat infection. Furthermore, evolving habits will further stimulate the development of the demand for throat lozenges, as modern lifestyles are responsible for reducing the body's immunity. These are sold in various varieties and are Over-the-Counter (OTC) products, making them easy for patients to use. Often, at the time of buying, throat lozenges do not require any prescriptions, resulting in quick commercialization of the medication. Due to an improvement in at-home care of sore throat and cough, the ease of distribution of these items stimulates consumer moving. Throat lozenges brands continue to exploit marketing tools to improve the commercial exposure of their label. The production of new products, rapid product penetration in fast-developing markets, and low prices of throat lozenges are other factors correlated with the growth of the global demand for throat lozenges.

Opportunities

Product Innovation to Create Growth Avenues for Key Players

Innovative product offerings which are expected to yield business prospects in the coming years are gradually being launched by market players. Brands are adding new flavours, which have a positive impact on the market, to give buyers more options.

Restraints

Access to Alternative OTC medication to Impede Market Growth

The availability of alternative over-the-counter medication methods for throat infections has led to developments in medicine and continuing study & development of alternative as well as more efficient treatments. Non-steroidal anti-inflammatory medications (NSAIDs) are useful for pain management and inflammation control, often related to a sore throat or throat infection. The development of the throat lozenges market is threatened by other substitutes such as throat sprays, cough syrups and antiseptic gargling solutions.

Segmental Analysis

By Type

More than 45 percent of the market comprises hard candy lozenges that come in a range of shapes, sizes, and tastes that make them particularly popular with people of ages. Compressed lozenges are the fastest-growing segment that will evolve during the appraisal period at a CAGR of 4.35 percent. Long-lasting compressed lozenges and an extended breakdown period offer long-lasting relief.

By Ingredient

Menthol accounts for the most relevant ingredient category and is estimated to be worth USD 2084.62 Mn by the end of the appraisal period. Although the compound itself has few medicinal advantages, the taste is incredibly common, placing it in a position of leadership. With the highest estimated CAGR of 4.72 percent during the forecast period, eucalyptus oil accounts for the fastest rising category. Eucalyptus oil is a historically used antibacterial component attributed to long-lasting soothing properties, making it increasingly popular.

By Indication

With respect to market share, the sore throat segment is well ahead of all other categories. Meanwhile, the cough & cold segment, which is predicted to undergo the highest CAGR of 4.51%, is the fastest rising segment. Combined with elevated cases of common cold, the infectious aspect of cough & cold is expected to fuel development in the market.

Regional Analysis

Presence of Major Players Drives North America

North America and South America are broadly split between the Americas, with a share of over 70 percent in the North American market. Due to the emergence of an increasingly growing ageing demographic, the Americas is the main regional consumer segment. Moreover, rising government spending and the presence of a wide range of product options push the market. One of the most significant markets at the national level is the U.S. The American economy is projected to expand at a CAGR of 3.27 percent during the estimation period.

Germany to Drive Europe Market Growth

In terms of market size, Europe leads the Americas and follows a similar pattern of growth. As main factors for the sector, growing government spending and a rising birth rate have been established. The development of Europe's demand for throat lozenges is motivated by the emergence in the area of a significant number of suppliers of throat lozenges, along with growing government spending and the availability of a wide range of product offerings. In addition, cool temperatures in countries accentuate the occurrence of cold and cough, which in turn fuels demand in the demand for European throat lozenges.

Rising Awareness of OTC Medicines to Drive APAC

Meanwhile, it is anticipated that the Asia Pacific market will be the fastest growing market, with a CAGR of 4.77 percent during the projected period. Emerging economies such as China, Japan, and India are among the markets in the region. Main drivers of the APAC industry have been found to be fast economic development, awareness of over-the-counter medicine and its cost-effectiveness. The area has a large paediatric population and an increasing geriatric population that also leads to the development of regional markets.

Competitive Landscape

Mergers and Acuisitions to Remain Primary Focus of Market Players

There are several competitors competing in the global market for throat lozenges. Global throat lozenges market is heavily saturated due to the involvement of a large number of local and multinational corporations. A vast variety of items on the market are available. The majority of businesses concentrate on cost-effective drugs, while others have embraced merger tactics and strategic partnerships for commercial expansion. Any of the major companies, taking advantage of their good position and presence in the number of countries and regions around the world, have gained a large share of the global market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212 

Digital Genome Market to Witness Widespread Expansion During 2020-2027

 Market Scenario

The global digital genome market is expected to witness tremendous growth during the forecast period. Digital genome can be used in the diagnosis of rare diseases, genetic diseases, cancer, neurological disorders and others. The rising prevalence of chronic diseases such as breast cancer is driving the market growth. Other essential factors influencing the growth of the market are increasing geriatric population, need for efficient diagnosis and treatment, increasing number of drug discoveries, growing biotech sector, increasing research in the field of genomics and rise in funding related to digitalization. Variants of Presenilin gene lead to Alzheimer’s disease. According to Alzheimer's Association in 2018, 5.7 million people are from Alzheimer’s disease in the Americas. With the help of digital genome identifying genomic variants is easy.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1125 

However, factors such as high costs of digital genome techniques, lack of knowledge about the digital genome, security issues and inaccurate results are some of the factors expected to hinder the market growth during the forecast period.

Global Digital Genome Market, by Key Players

• Umbel
• BiogeniQ
• GenomeMe
• NanoString
• Illumina, Inc

Segmentation

The global digital genome market is segmented on the basis of product, application, and end-user.  The global digital genome market, by product, is segmented into sequencing services, sequencing instruments, sequencing consumables, bioinformatics and sample preparation kits and reagents. The application segment is segmented into diagnostics, agriculture & animal research, personalized medicine, drug discovery and treatment analysis.  On the basis of end-user, the market is categorized into research centers and government institutes, academic institutions, pharmaceutical & biotechnology industries, hospitals, and diagnostic centers. On the basis of region, the global digital genome market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Regional Market Summary

The digital genome market is dominated by America owing increasing prevalence of chronic diseases like cancer and diabetes. The Breastcancer.org estimated 266,120 new cases of invasive breast cancer and 63,960 new cases of non-invasive breast cancer in America in 2018. Thus, this provides favorable backgrounds for the market to grow.

It is estimated that Europe stood second in the global digital genome market. The rising demand for personalized medicine and targeted therapy is driving the growth of the market. The European Alliance for Personalized Medicine (EAPM) founded in March 2012, is involved in enhancing patient care for chronic diseases through personalized medicine. According to the European Commission in April 2018, 13 European countries have signed a declaration to share the genomic data to allow personalized treatments against cancer, rare diseases, and neurological diseases.

The digital genome market in Asia-Pacific is expected to witness growth owing to rising diabetes in this region. According to the American Diabetes Association in 2016, the Western Pacific has more than 138.2 million diabetic patients. Also, the rising healthcare spending and growing biotech sector drive the market growth in this region.

The Middle East and Africa holds the least share in the global digital genome market due to low funding in medical and health research. However, the rising prevalence of chronic diseases and increasing healthcare spending favors market growth in this region. According to the Ministry of Finance - KSA (Kingdom of Saudi Arabia) in 2018, 147 billion riyals (USD 39.2 billion) have been allocated for the Health and Social Development Sector. This enhances the market growth of digital genome in this region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/digital-genome-market-1125 

Global Patient Handling Equipment Market Industry Production and Demand, Competition News and Trends Forecasts to 2027

 Market Forecast

Global Patient Handling Equipment Market is expected to be valued at USD 15,430.18 Million by 2027 at a CAGR of 8.3% during the forecast period, 2020-2027.

The advancement in patient handling equipment and expansion of healthcare infrastructure due to the COVID-19 pandemic is expected to boost the growth of the market in the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/9986 

Market Synopsis

An increasing usage of patient handling equipment in hospitals, rehabilitation centers, and elderly care settings is expected to drive the growth of the global patient handling equipment market.

The market growth in the coming years can also be attributed to the business expansion of manufacturers through merger & acquisition and incessant launch of innovative products. For instance, in the year 2020, Invacare Corporation, a US-based long-term medical product manufacturer, announced the launch of an Invacare AVIVA FX Power Wheelchair, a front-wheel-drive wheelchair. This product launch was aimed to strengthen the company’s power mobility product portfolio.

Market USP

Growing patient population of chronic diseases and rising geriatric population are the major market influencer of the patient handling equipment market.  

Market Drivers

The rising influx of patients in the hospital due to an outbreak of COVID-19 pandemic. The critical care products including hospital beds, ventilators, and vitals monitoring devices are being used in abundance for patients suffering from COVID-19. Various companies are aiding the healthcare sector in meeting the rising demand for critical care products by increasing their manufacturing capacity. For instance, in May 2020, Stryker (US) delivered about 1,000 emergency relief beds to hospitals in Qatar. The company is also massively producing emergency relief beds, a low-cost hospital bed.      

• Increasing geriatric and obese population

• Risk of injuries to caregivers while manual handling of patients

• Implementation of regulations to ensure the safety of healthcare service providers during the manual lifting procedure. For instance, according to the Office of State Human Resources (OSHR), the caregiver should do a preliminary assessment of their safety & health risks before any manual handling operation and take appropriate steps to lower the risks of patient handling. Also, manual handling operations should be avoided as far as it is reasonably practicable.

• A growing number of road accidents

• Growing usage of ceiling lifts in hospitals

Market Restraints

• Low skilled professionals for the efficient operation of the patient handling equipment.

Segmentation

By Product

• Patient Transfer Devices: This segment is likely to hold the largest share owing to the growing number of obese patients. This segment is further fragmented into patient lifts, air-assisted lateral transfer mattresses, sliding sheets, and accessories. Patient transfer devices aid in long and short distance transfer of patients depending on the requirement. Also, these products provide caregivers reduced risk of injuries while patient handling and are time efficient. According to National Public Radio, every year about 35,000 nursing professionals experience back and body injuries during patient handling in the US region.

• Medical Beds: This segment is further segmented into manual beds, electric beds, and semi-electric beds. The rising number of COVID-19 patients has influx the demand for medical beds in the forecast period. Also, the growing geriatric population base susceptive to chronic disease will be driving the growth of the segment. For instance, in 2019, according to the United Nations, globally there were about 703 million people aged 65 or over.

• Mobility Devices: This segment is further segmented into wheelchairs & mobility scooters, and ambulatory aids. The increasing cases of disability are expected to propel the demand for mobility devices. The ambulatory aid equipment provides support, stability, and balance for patients. The ambulatory aid segment includes equipment such as crutch, cane walking, walker, and others.

• Bathroom & Toilet Assist Equipment: These segments include bathroom assist products such as commodes, bath aids, handgrips, bath lifts, shower chairs, and others. Easy availability in online stores is likely to propel the growth of the segment.

• Stretchers & Transport Chairs: These are used in carrying patients from one place to another, within and outside of a healthcare facility. The advancement in stretchers & transport chairs has been enabling clinicians in providing patients with proper emergency assistance.

By Application

• Acute & Critical Care: This segment is likely to hold the largest share owing to high prevalence rate cardiovascular diseases, viral infection, and other acute diseases. For instance, in 2017, according to the Centers for Disease Control and Prevention (CDC), about 18.2 million adult population aged 20 or older were suffering from coronary heart disease in the US region.

• Long Term Care: This segment is likely to be the fastest-growing segment owing to the growing prevalence of target diseases such as tuberculosis, Alzheimer’s disease, tetanus, and others. For instance, according to Alzheimer's Association, in the US, about 5.8 million people aged 65 or above were suffering from Alzheimer’s dementia in 2019 and 5.7 million in 2018.

• Mobility Assistance: The growth of this segment can be attributed to the growing incidence rate of diseases such as arthritis and Parkinson’s.  For instance, according to Parkinson's Foundation, every year about 60,000 of the American population are diagnosed with Parkinson’s disease. This disease is characterized by stiffness, slowed movement, tremors, and impaired balance. The mobility assistance devices improve balance and provide support to patients suffering from Parkinson’s disease. Also, the rising elderly population is expected to drive the growth of the segment.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Stethoscope Market Dynamics, Segments and Supply Demand 2020-2027

 The global stethoscope market is expected to grow significantly over the forecast period. It is estimated that the global stethoscope market is expected to register a CAGR ~ 4.6% during the forecast period of 2019 to 2024 with an estimated market value of USD 332.1 million in 2018.

The global market is driven by factors such as increasing incidence rate of life-threatening diseases, increased spending on healthcare and ongoing research and development. Moreover, growing technological advancements such as Bluetooth connectivity with digital wireless hearing aids is expected to fuel the growth of the market during the assessment period. Furthermore, increasing innovations in the field of healthcare have pushed for the growth of the market. For instance, in October 2018, researchers from Rochester Institute of Technology and University of Rochester Medical Center developed a new electronic stethoscope that combines precision sensors, electrocardiogram technology, and machine learning applications into one piece of equipment to better detect heart ailments and problems that might occur with an implanted heart pump. Similarly, in March 2018, Neurologists from Stanford University developed brain stethoscope that can translate the brain’s activity into sounds so that silent seizures can be detected. On the other hand, poor healthcare system and less access to health services in certain economies are restraining the growth of stethoscope market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7802

Moreover, major companies in the market are involved in strategic collaborations to brace their position in the market. For instance, in September 2015, eKuore launched its first wireless stethoscope in Düsseldorf, Germany. 

Segmentation

The global stethoscope market has been segmented into type, and end user. The market, based on type, has been segmented into manual stethoscope and electronic stethoscope. The market, by manual stethoscope, has been further segmented into a fetal stethoscope, and others. The market, by electronic stethoscope, has been sub-segmented into esophageal stethoscopes, fetal heart rate detectors, and others. The market, by end user, has been segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are expected to hold a major share in the end user segment owing to the increased occurrences of diseases, as well as the rise in the patient visits. Clinics are projected to be the fastest growing segment due to the ease of accessibility it provides to the patients.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The stethoscope market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European stethoscope market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The stethoscope market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The stethoscope market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

3M, A&D Medical, American Diagnostic Corporation, Cardionics, GF Health Products, Heine Optotechnik, McCoy Medical, Medline Industries, Omron Corporation, Rudolf Riester, Smith’s Medical, and Welch Allyn are some of the key players in the global stethoscope market.

Regional Market Summary

Geographically, the Americas is expected to dominate the global stethoscope market due to the increasing per capita healthcare expenditure. The rise in product innovation and the heavy adoption of new technology is anticipated to drive the growth of the market.

Europe showed a considerable amount of growth in the global stethoscope market. The market growth in this region is because of the presence of a well-established healthcare system. The rise in the patient population is also contributing to the growth in the region.

Asia-Pacific is estimated to be the fastest growing region in the market due to a rise in the number of health welfare programs. This growing awareness in Asian countries by public and private organizations is projected to fuel the growth of the market during the assessment period. On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/stethoscope-market-7802

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Impact of Existing and Emerging Global Healthcare Information Systems Market Trends And Forecast 2020-2027

 The global healthcare information systems market is expected to register a CAGR of 10.0% during the forecast period of 2018 to 2023.

Healthcare information technology offers solutions for security and data management of information related with healthcare. Currently, information technology has more effect on the cost quality and safety associated with healthcare. Some commonly used applications in the healthcare industry include electronic medical records, healthcare records and personal health records.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7325

Healthcare Information Systems Market Segmentation

The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.

On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.

Healthcare Information Systems Regional Market Summary

The Americas dominated the global market of healthcare information systems. Rising demand for high quality diagnostics system is the main reason behind the supremacy of the North America’s healthcare information system market. Furthermore, large-scale implementation and storage of electronic records in the healthcare system witnessed in the countries such as Canada and the U.S is supporting the expansion of this regional healthcare information system market.

In 2017, it was estimated that Europe stood second in the global healthcare information systems market. This can be attributed due to the presence of a well-developed healthcare infrastructure, increasing awareness for the condition and presence of developed economies within the region.

Asia Pacific was the fastest growing region for the global healthcare information systems market in 2017. Asia-Pacific has a huge market potential for Healthcare IT industry. India and China are some of the rapidly growing countries, followed by South Korea. Consequently, the government in these rapidly developing economies have taken various efforts to improve healthcare services and provide better infrastructure.

On the other hand, the Middle East and Africa held least share in the global healthcare information systems market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com